Kewaunee Scientific (NASDAQ:KEQU) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $42.85 and traded as high as $63.23. Kewaunee Scientific shares last traded at $61.10, with a volume of 53,912 shares trading hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Stock Performance

The company has a market capitalization of $182.59 million, a PE ratio of 10.08 and a beta of 0.80. The stock’s fifty day simple moving average is $41.99 and its 200-day simple moving average is $43.12. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53.

Insider Activity at Kewaunee Scientific

In related news, CFO Donald T. Gardner III sold 2,049 shares of the stock in a transaction dated Tuesday, December 24th. The stock was sold at an average price of $58.19, for a total transaction of $119,231.31. Following the transaction, the chief financial officer now directly owns 22,615 shares in the company, valued at approximately $1,315,966.85. This represents a 8.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the completion of the sale, the vice president now owns 13,591 shares of the company’s stock, valued at $736,224.47. This trade represents a 11.98 % decrease in their position. The disclosure for this sale can be found here. Insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On Kewaunee Scientific

A number of hedge funds have recently made changes to their positions in KEQU. Dimensional Fund Advisors LP raised its holdings in shares of Kewaunee Scientific by 3.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the period. Renaissance Technologies LLC raised its stake in shares of Kewaunee Scientific by 13.4% in the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after acquiring an additional 10,580 shares during the period. De Lisle Partners LLP boosted its position in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after purchasing an additional 11,511 shares during the period. Geode Capital Management LLC increased its holdings in Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares in the last quarter. Finally, Ritholtz Wealth Management lifted its stake in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after purchasing an additional 2,156 shares in the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.